WallStreetZenWallStreetZen

NASDAQ: EOLS
Evolus Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for EOLS

Based on 5 analysts offering 12 month price targets for Evolus Inc.
Min Forecast
$16.00+38.41%
Avg Forecast
$22.60+95.5%
Max Forecast
$27.00+133.56%

Should I buy or sell EOLS stock?

Based on 5 analysts offering ratings for Evolus Inc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EOLS stock forecasts and price targets.

EOLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-08Find Out Why
lockedlocked$00.00+00.00%2024-03-08
lockedlocked$00.00+00.00%2024-03-08
lockedlocked$00.00+00.00%2024-01-29

1 of 1

Forecast return on equity

Is EOLS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is EOLS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EOLS revenue forecast

What is EOLS's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$262.6M+29.96%
Avg 2 year Forecast
$341.5M+69.01%
Avg 3 year Forecast
$450.5M+122.93%
EOLS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EOLS revenue growth forecast

How is EOLS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
30.63%
Industry
9.04%
Market
10.23%
EOLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EOLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EOLS vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
EOLS$11.56$22.60+95.50%Strong Buy
CGC$7.83N/AN/A
SIGA$8.23N/AN/A
PAHC$13.04$16.00+22.70%Hold
PETQ$16.03$28.00+74.67%Strong Buy
View Top Pharmaceutical Stocks

Evolus Stock Forecast FAQ

Is Evolus Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: EOLS) stock is to Strong Buy EOLS stock.

Out of 5 analysts, 3 (60%) are recommending EOLS as a Strong Buy, 2 (40%) are recommending EOLS as a Buy, 0 (0%) are recommending EOLS as a Hold, 0 (0%) are recommending EOLS as a Sell, and 0 (0%) are recommending EOLS as a Strong Sell.

If you're new to stock investing, here's how to buy Evolus stock.

What is EOLS's revenue growth forecast for 2024-2026?

(NASDAQ: EOLS) Evolus's forecast annual revenue growth rate of 30.63% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Evolus's revenue in 2024 is $202,085,000.On average, 3 Wall Street analysts forecast EOLS's revenue for 2024 to be $15,217,907,277, with the lowest EOLS revenue forecast at $15,080,407,062, and the highest EOLS revenue forecast at $15,316,817,039. On average, 3 Wall Street analysts forecast EOLS's revenue for 2025 to be $19,790,238,489, with the lowest EOLS revenue forecast at $18,986,966,057, and the highest EOLS revenue forecast at $20,268,678,976.

In 2026, EOLS is forecast to generate $26,104,181,147 in revenue, with the lowest revenue forecast at $25,361,923,349 and the highest revenue forecast at $26,803,560,665.

What is EOLS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: EOLS) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is EOLS's Price Target?

According to 5 Wall Street analysts that have issued a 1 year EOLS price target, the average EOLS price target is $22.60, with the highest EOLS stock price forecast at $27.00 and the lowest EOLS stock price forecast at $16.00.

On average, Wall Street analysts predict that Evolus's share price could reach $22.60 by Apr 10, 2025. The average Evolus stock price prediction forecasts a potential upside of 95.5% from the current EOLS share price of $11.56.

What is EOLS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: EOLS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.